Cargando…
The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305444/ http://dx.doi.org/10.1186/1532-429X-14-S1-P48 |
| _version_ | 1782227071460704256 |
|---|---|
| author | Crowley, Anna Lisa Kim, Han W Parker, Michele Spatz, Deneen Hayes, Brenda Bhatti, Lubna Jensen, Christoph J Ngo, Jessica Papalas, John A Pun, Patrick Middleton, John P Judd, Robert M Kim, Raymond J |
| author_facet | Crowley, Anna Lisa Kim, Han W Parker, Michele Spatz, Deneen Hayes, Brenda Bhatti, Lubna Jensen, Christoph J Ngo, Jessica Papalas, John A Pun, Patrick Middleton, John P Judd, Robert M Kim, Raymond J |
| author_sort | Crowley, Anna Lisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3305444 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33054442012-03-16 The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance Crowley, Anna Lisa Kim, Han W Parker, Michele Spatz, Deneen Hayes, Brenda Bhatti, Lubna Jensen, Christoph J Ngo, Jessica Papalas, John A Pun, Patrick Middleton, John P Judd, Robert M Kim, Raymond J J Cardiovasc Magn Reson Poster Presentation BioMed Central 2012-02-01 /pmc/articles/PMC3305444/ http://dx.doi.org/10.1186/1532-429X-14-S1-P48 Text en Copyright ©2012 Crowley et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Crowley, Anna Lisa Kim, Han W Parker, Michele Spatz, Deneen Hayes, Brenda Bhatti, Lubna Jensen, Christoph J Ngo, Jessica Papalas, John A Pun, Patrick Middleton, John P Judd, Robert M Kim, Raymond J The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| title | The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| title_full | The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| title_fullStr | The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| title_full_unstemmed | The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| title_short | The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| title_sort | incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305444/ http://dx.doi.org/10.1186/1532-429X-14-S1-P48 |
| work_keys_str_mv | AT crowleyannalisa theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT kimhanw theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT parkermichele theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT spatzdeneen theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT hayesbrenda theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT bhattilubna theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT jensenchristophj theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT ngojessica theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT papalasjohna theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT punpatrick theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT middletonjohnp theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT juddrobertm theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT kimraymondj theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT crowleyannalisa incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT kimhanw incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT parkermichele incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT spatzdeneen incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT hayesbrenda incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT bhattilubna incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT jensenchristophj incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT ngojessica incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT papalasjohna incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT punpatrick incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT middletonjohnp incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT juddrobertm incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance AT kimraymondj incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance |